| 000 | 01881 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250517155806.0 | ||
| 264 | 0 | _c20170919 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1932-6203 | ||
| 024 | 7 |
_a10.1371/journal.pone.0178905 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWang, Jianxun | |
| 245 | 0 | 0 |
_aIn vivo efficacy of the AKT inhibitor ARQ 092 in Noonan Syndrome with multiple lentigines-associated hypertrophic cardiomyopathy. _h[electronic resource] |
| 260 |
_bPloS one _c2017 |
||
| 300 |
_ae0178905 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAminopyridines _xpharmacology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCardiomyopathy, Hypertrophic _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aEchocardiography |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImidazoles _xpharmacology |
| 650 | 0 | 4 |
_aLEOPARD Syndrome _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Transgenic |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aPhosphoproteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProtein Domains |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProtein Tyrosine Phosphatase, Non-Receptor Type 11 _xgenetics |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xgenetics |
| 700 | 1 | _aChandrasekhar, Vasanth | |
| 700 | 1 | _aAbbadessa, Giovanni | |
| 700 | 1 | _aYu, Yi | |
| 700 | 1 | _aSchwartz, Brian | |
| 700 | 1 | _aKontaridis, Maria I | |
| 773 | 0 |
_tPloS one _gvol. 12 _gno. 6 _gp. e0178905 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1371/journal.pone.0178905 _zAvailable from publisher's website |
| 999 |
_c27246938 _d27246938 |
||